drugset / Trial / NCT06182696
OriCAR-017 Chimeric Antigen Receptor (CAR) Modified T Cells for the Treatment of R/RMM
NaSingle-groupOpen-labelTreatment
Summary
An open label, dose exploratory clinical study to evaluate the safety, efficacy, and pharmacokinetics of OriCAR-017 in R/RMM
Timeline
- Start
- 2023-10-26
- Primary completion
- 2026-11-30
- Completion
- 2028-08-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | OriCAR-017 | Cell therapy | — | — |